Spyglass Pharma target price raised to $43 from $37 by H.C. Wainwright
SGP•H.C. Wainwright raised its target price for Spyglass Pharma to $43 from $37.
Related News
Nasdaq trade halt: volatility trading pause at 9:58 a.m.
NXPL•
CVS Pharmacy launches latest collection of Caliber Artist Series colleague-designed journals
CVS•
Myomo expects cash burn below $2 million in second half of 2026
MYO•
Vylor sees record grain, oilseed and biofuel demand supporting 2027 outlook
VYLR•
Organon’s VTAMA shows consistent efficacy across atopic dermatitis subgroups in pooled Phase 3 analysis
OGN•